News

3D printing and IP in a pandemic

As the technology is increasingly being used to manufacture vital supplies a balance can be struck between protecting rights and helping the fight against covid-19

3D printing and IP in a pandemic
Ericsson CEO strikes optimistic tone, but wireless industry waits to feel full effects of covid-19
2 Apr 2020

Ericsson CEO strikes optimistic tone, but wireless industry waits to feel full effects of covid-19

Björe Ekholm points to strength of company's patent portfolio as ongoing reason for optimism; meanwhile InterDigital improves Q1 guidance after sealing two new licensing deals

From the <em>IAM</em> archive - setting the standard
1 Apr 2020

From the IAM archive - setting the standard

A look back into our 17-year back catalogue at some of the outstanding content we have published on this vital subject

Latest

View all news
31 Mar 2020

How covid-19 is impacting US district courts and the PTAB

The ongoing pandemic is having a big impact on patent disputes as litigants adapt to new court directives Read more

30 Mar 2020

No strings Covid-19 IP pledge initiative underlines delicate balance biopharma businesses must strike

“It’s not perfect but it’s something,” admits co-founder, as rights owners face growing pressure to waive their rights in face of pandemic Read more

30 Mar 2020

Top tips from legal IP elite

Insights from the winners of the 2020 Global IP Awards Read more

30 Mar 2020

How life sciences innovators can avoid patent term extension pitfalls in Japan

Uncertainties remain over the claim scope that can be covered by PTEs in the country, and difficulties can arise when more than one extension is claimed for a single patent Read more

30 Mar 2020

IP-focused arbitration centre seeks to head off legal disputes caused by pandemic

Many court dockets are on hold, but IP disputes are not. Ocean Tomo and the International Arbitration Centre Tokyo think ADR can help bridge the gap Read more

29 Mar 2020

Global patent filings to plunge; Nokia’s missing royalties; Huawei’s IV deal; F1 patent battle begins; Reasons for IP optimism despite Covid-19 crisis; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

28 Mar 2020

This, too, shall pass ...

The world is hurting, times are tough, but even as they endure pain today IP professionals can look forward to a golden, new dawn Read more

27 Mar 2020

From the IAM archive – corporate IP success stories

The inside story on how TD Bank, Dolby Labs, LinkedIn, Siam Cement, Rockwell Collins and Google built strategies to maximise the value of their assets Read more

27 Mar 2020

What you need to know about patent extension rights in Israel

Uncertainties persist over the protection of biological inventions and how Israeli extensions are pegged to PTEs in other countries Read more

26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market Read more

25 Mar 2020

Race against the virus: covid-19 clinical trial pharmaceutical patents in Taiwan

The outbreak of the novel coronavirus is affecting every aspect of the global community. As a result, researchers and pharmaceutical companies are moving as fast as possible to develop drugs to combat the pandemic. Read more

24 Mar 2020

Covid-19 emergency may expose compulsory licensing limits

Government responses to the pandemic could include increased focus on obligatory sharing of patented inventions, but regulatory data exclusivities might serve as a barrier in both Europe and the United States. Read more

23 Mar 2020

In the fight against the coronavirus outbreak, life sciences companies need certainty in 101

An increase in R&D around the COVID-19 crisis could lead to a surge in innovation, but inventors will need to be sure what is patentable Read more

22 Mar 2020

Free COVID-19 coverage; German court puts UPC on life support; Ex-Microsoft patent head joins Marconi; Sharp attacks Tesla; IBM top for 2019 patent sales; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

21 Mar 2020

Some licensors are taking a much more public stand in their FRAND fights - here's why

Recents moves by Nokia and InterDigital show that rights owners are beginning to realise that winning the PR battle is just as important as prevailing in court Read more

19 Mar 2020

Final call for IP Hall of Fame 2020 nominations

You have until the end of the week to put forward names for consideration Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

17 Mar 2020

After Theranos suit, Fortress makes patents available on royalty-free basis for COVID-19 tests

IP investment giant makes move after French defendant announces it has launched three tests relating to coronavirus Read more

17 Mar 2020

All IAM Covid-19 coverage to be free to view

As from today, all the features we run relating to the coronavirus pandemic will be put in front of our paywall Read more

16 Mar 2020

Donation is no defence to patent infringement in China

A company’s announced plans to give away a patented antiviral drug to treat Covid-19 would not protect it from infringement claims under Chinese law, but it could make a court less likely to award injunctive relief Read more

15 Mar 2020

Samsung quits MPEG-LA; Coronavirus IP dangers; Fortress makes Theranos play; Sisvel expands video coding licensing reach; Patents drive massive medtech deal; and much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

14 Mar 2020

The danger COVID-19 presents to biopharma patent owners

If they were to mishandle their response to the coronavirus pandemic, innovative life sciences companies could further polarise opinion on IP protection in the sector Read more

13 Mar 2020

Hytera: TRO in Motorola trade secrets case could hamper coronavirus response

US company that won $764m jury verdict last month says it can meet global demand with interoperable radio products Read more

8 Mar 2020

$40bn corporate patent spend revealed; WIPO to get first Asian DG; Nokia IP head’s message to auto; Pharma patent sales boom; EPO president exclusive; and much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

6 Mar 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible Read more

1 Mar 2020

UK says “No” to UPC; Biggest US portfolios revealed; Biopharma IP transactions boost; RPX seals major Yahoo! patent deal; NPEs drive China litigation boom; and much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

27 Feb 2020

The UK will not be part of the UPC, government confirms to IAM

"Participating in a court that applies EU law and bound by the CJEU is inconsistent with our aims of becoming an independent self-governing nation," says spokesperson Read more

26 Feb 2020

Top Chinese official stresses need for strong pharma patents amidst Covid-19 outbreak

He Zhimin, the deputy director of the country's National IP Administration, was responding to media reports over the protection status of Gilead anti-viral remdesivir Read more

25 Feb 2020

Compete, monetise, abandon: the strategic path to IP value

Getting to know what is in your portfolio – and why – is the first step to making the most of it Read more

23 Feb 2020

A new $500 million licensing giant; Covid-19 stalls key China patent case; Lawyers feel PTAB slump; Amgen’s big biosimilars win; NPE sues Uber with ex-IBM IP; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

22 Feb 2020

It’s time to take a different approach to appointing the USPTO head

Taking a longer term view would bring consistency and might help US innovation policy at a time of rising tech competition from China and elsewhere Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

16 Feb 2020

Coronavirus hits global IP market; Toshiba’s big patent moves; It’s McCurdy’s RPX now; Four vie for self-drive patent lead; Germany injunction threat; plus much more

Get ready for the new working week with a summary of all the stories posted on the IAM platform over the past seven days Read more

15 Feb 2020

The impact of Covid-19 will be felt across the global IP market

The race to patent a treatment for coronavirus in China is heating up, but its spread could be the story that affects every other story in tech this year Read more

12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

View all news